Eleanor F. Gerhard

Eleanor F. Gerhard

Auto-generated profile, based on publicly available information

Eleanor F. Gerhard

Weill Cornell Medical College, New York, NY (E.G.).

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in The Bone & Joint Journal
Verified
Journal Article
Closed access
AGAlex Gu
Alex Gu
MMMichael-Alexander Malahias
Michael-Alexander Malahias
NSNicolas A. Selemon
Nicolas A. Selemon
CWChapman Wei
Chapman Wei
EGEleanor F. Gerhard
Eleanor F. Gerhard
PSPeter K. Sculco
Peter K. Sculco
Aims: The aim of this study was to determine the impact of the severity of anaemia on postoperative complications following total hip arthroplasty (THA) and total knee arthroplasty (TKA). Methods: A retrospective cohort study was conducted using the American College of Surgeons National Quality Improvement Program (ACS-NSQIP) database. All patients who underwent primary TKA or THA between January 2012 and December 2017 were identified and stratified based upon hematocrit level. In this analysis, we defined anaemia as packed cell volume (Hct) < 36% for women and < 39% for men, and further stratified anaemia as mild anaemia (Hct 33% to 36% for women, Hct 33% to 39% for men), and moderate to severe (Hct < 33% for both men and women). Univariate and multivariate analyses were used to evaluate the incidence of multiple adverse events within 30 days of arthroplasty. Results: Following adjustment, patients in the THA cohort with moderate to severe anaemia had an increased odds of 6.194 (95% confidence interval (CI) 5.679 to 6.756; p < 0.001) for developing any postoperative complication. Following adjustment, patients in the TKA cohort with moderate to severe anaemia had an increased odds of 5.186 (95% CI 4.811 to 5.590; p < 0.001) for developing any postoperative complication. Among both cohorts, as severity increased, there was an increased risk of postoperative complications. Conclusion: Preoperative anaemia is a risk factor for complications following primary arthroplasty. There is a significant relationship between the severity of anaemia and the odds of postoperative complications. Patients who had moderate to severe anaemia were at increased risk of developing postoperative complications relative to patients with mild anaemia. When considering elective primary THA or TKA in a moderately or severely anaemic patient, surgeons should strongly consider correcting anaemia prior to surgery if possible. Cite this article: Bone Joint J 2020;102-B(4):485–494.

11 August 2021 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
EGEleanor F. Gerhard
Eleanor F. Gerhard
LWLu Wang
Lu Wang
RSRamesh Singh
Ramesh Singh
SSStephan Schueler
Stephan Schueler
LGLeonard D. Genovese
Leonard D. Genovese
PSPalak Shah
Palak Shah

1 December 2024 in Circulation: Heart Failure
Verified
Journal Article
Closed access
JGJason F. Goldberg
Jason F. Goldberg
XTXin Tian
Xin Tian
ABAnn Bon
Ann Bon
YXYifei Xu
Yifei Xu
EGEleanor Gerhard
Eleanor Gerhard
SASean Agbor-Enoh
Sean Agbor-Enoh
BACKGROUND: Heart transplant recipients with donor-specific antibodies (DSAs) have an increased risk for antibody-mediated rejection. However, many patients with graft dysfunction and DSA do not have evidence of antibody-mediated rejection by endomyocardial biopsy (EMB). METHODS: Participants from this prospective, multicenter study underwent serial EMB, echocardiogram, DSA, and donor-derived cell-free DNA evaluations. Outcomes were defined as pAMR+ (pAMR≥1) or DSA+/left ventricle (LV) dysfunction (DSA presence+LVEF drop ≥10% to an LVEF≤50%). Cox regression evaluated the association between antibody-mediated rejection categories and death or sustained (for 3 months) reduction of LVEF to <50%. RESULTS: Two hundred sixteen patients (29% women, 39% Black race, median age 55 [interquartile range, 47–62] years) had 1488 EMB, 2792 DSA, 1821 echocardiograms, and 1190 donor-derived cell-free DNA evaluations. DSAs were present in 86 patients (40%). Fourteen patients had isolated pAMR+ episodes and 8 patients had isolated DSA+/LV dysfunction episodes; 2 patients had pAMR+ and then subsequently DSA+/LV dysfunction with pAMR+. Median %dd-cfDNA was significantly higher at diagnosis of pAMR+ (0.63% [interquartile range, 0.23–2.0]; P =0.0002), or DSA+/LV dysfunction (0.40% [interquartile range, 0.36–1.24]; P <0.0001), compared with patients without these outcomes (0.01% [interquartile range, 0.0001–0.10]). Both pAMR+ and DSA+/LV dysfunction were associated with long-term clinical outcome of death (n=18) or prolonged LV dysfunction (n=10): pAMR+ (hazard ratio, 2.8 [95% CI, 1.03–7.4]; P =0.043); DSA+/LV dysfunction (hazard ratio, 26.2 [95% CI, 9.6–71.3]; P <0.001); composite of both definitions (hazard ratio, 6.5 [95% CI, 2.9–14.3]; P <0.001). Patients who developed pAMR+ or DSA+/LV dysfunction within the first 6 months of transplant were more likely to die within 3 years posttransplant (hazard ratio, 3.9 [95% CI, 1.03–14.6]; P =0.031). CONCLUSIONS: Expanding the characterization of antibody-mediated rejection to include patients with DSA and concurrent allograft dysfunction identified DSA+ patients at risk for death and prolonged LV dysfunction.

3 December 2019 in The Journal of Knee Surgery
Verified
Journal Article
Closed access
PDF file
AGAlex Gu
Alex Gu
EGEleanor F. Gerhard
Eleanor F. Gerhard
CWChapman Wei
Chapman Wei
PBPatawut Bovonratwet
Patawut Bovonratwet
SSSeth Stake
Seth Stake
AMAlexander S. McLawhorn
Alexander S. McLawhorn
Total knee arthroplasty (TKA) is becoming an increasingly common procedure to alleviate knee pain often associated with osteoarthritis. As the number of revision TKAs performed continues to increase, there remains a debate regarding the efficacy of discharging patients earlier than the conventional 3 to 4 days in the postoperative period. A variety of studies have begun to show that interchangably discharge in the primary TKA setting has an economical benefit while causing either a reduction or no difference in patient outcomes. This study aims to determine the effect of rapid discharge at 0- to 2-day postoperative stay compared to the conventional 3- to 4-day postoperative stay on postdischarge complications in patients undergoing revision TKA. A retrospective cohort study was conducted using data collected through the American College of Surgeons National Quality Improvement Program Database. All patients who underwent aseptic revision TKA between 2005 and 2016 were identified and stratified into groups based on length of stay: 0 to 2 days versus 3 to 4 days. Patients suffering from predischarge complications were excluded to minimize bias. Single-component versus both-component revisions were analyzed. The incidence of adverse events following discharge was evaluated with univariate and logistic multivariate analyses where appropriate. Patients who underwent single-component revisions and were discharged rapidly were less likely to develop minor complications (p = 0.001; odds ratio [OR]: 0.355; 95% confidence interval [CI]: 0.188–0.671) and septic complications (p = 0.016; OR: 0.011; 95% CI: 0–0.430) within the 30-day postoperative period. No differences were observed in discharge cohorts among patients undergoing both-component revisions. We found that rapid discharge following aseptic revision TKA is not associated with increased risks for postoperative complications. Rapid discharge may have benefits for healthy patients undergoing single-component revisions. Careful selection of revision TKA patients for rapid discharge may help to lower the increasing costs of the procedure and improve patient outcomes. Further study is required to refine the selection criteria to identify patients eligible for short stay or outpatient revision TKA.

7 November 2023 in Circulation
Verified
Journal Article
Closed access
JGJason F Goldberg
Jason F Goldberg
YXYifei Xu
Yifei Xu
XTXin Tian
Xin Tian
EGEleanor Gerhard
Eleanor Gerhard
RBRuth Brower
Ruth Brower
SASean Agbor-Enoh
Sean Agbor-Enoh